Literature DB >> 30334235

Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium.

Sebastiano Mercadante1, Francesco Masedu2, Marco Maltoni3, Daniela De Giovanni4, Luigi Montanari5, Cristina Pittureri6, Raffaella Bertè7, Domenico Russo8, Laura Ursini9, Franco Marinangeli10, Federica Aielli11.   

Abstract

The aim of this study is to investigate the relationship between delirium and symptom expression in advanced cancer patients admitted to palliative care services. This is a secondary analysis of a consecutive sample of advanced cancer patients who were admitted to home care and hospices, and prospectively assessed for a period of 10 months. The Edmonton Symptom Assessment Scale (ESAS) and the MDAS (Memorial Delirium Assessment Scale) were measured at admission (T0) and after seven days of home care or hospice care (T7). Of the eight hundred and forty-eight patients screened in the period, 585 were not considered in the analysis for various reasons. The mean age was 72.1 years (SD 13.7), and 146 patients were males (55.5%). The mean Karnofsky status recorded at T0 is 34.1 (SD = 6.69). The mean duration palliative care assistance is 38.4 days (SD = 48, range 2-220). Of 263 patients who had a MDAS available at T0, 110 patients (41.8%) had a diagnosis of delirium. Of them, 167 patients had complete data regarding MDAS measurement, either at T0 and T7. A larger number of patients (n 167, 63.5%) had delirium after a week of palliative care. Patients with delirium are likely to be older, to have a lower Karnofsky level at T0, and to be home care patients. At T0, weakness, nausea, drowsiness, lack of appetite, and well-being are associated with delirium. At T7, weakness, poor appetite, and poor well-being are significantly associated with delirium. 27% of patients who had a normal cognitive status at T0 developed delirium at T7. In patients with delirium, an improvement in the cognitive status corresponds to a significant improvement in weakness, depression, and appetite. Conversely, the occurrence of delirium in patients who had a normal cognitive status at admission significantly increases the level depression, while the level of weakness and appetite decrease. Symptom expression is amplified in patients with delirium admitted to home care or hospices, while patients without delirium can be more responsive to palliative treatments with a significant decrease in intensity of ESAS items.

Entities:  

Keywords:  Advanced cancer; Delirium; Edmonton Symptom Assessment Scale; Memorial Delirium Assessment Scale; Palliative care

Mesh:

Year:  2018        PMID: 30334235     DOI: 10.1007/s11739-018-1969-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

1.  Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium.

Authors:  Emanuela Scarpi; Marco Maltoni; Rosalba Miceli; Luigi Mariani; Augusto Caraceni; Dino Amadori; Oriana Nanni
Journal:  Oncologist       Date:  2011-10-31

2.  Palliative sedation in patients with advanced cancer followed at home: a prospective study.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Alessandro Valle; Federica Aielli; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2013-10-05       Impact factor: 3.612

Review 3.  Neuropathogenesis of delirium: review of current etiologic theories and common pathways.

Authors:  José R Maldonado
Journal:  Am J Geriatr Psychiatry       Date:  2013-12       Impact factor: 4.105

4.  Increased Symptom Expression among Patients with Delirium Admitted to an Acute Palliative Care Unit.

Authors:  Maxine de la Cruz; Sriram Yennu; Diane Liu; Jimin Wu; Akhila Reddy; Eduardo Bruera
Journal:  J Palliat Med       Date:  2017-02-03       Impact factor: 2.947

5.  How do cancer patients receiving palliative care at home die? A descriptive study.

Authors:  Sebastiano Mercadante; Alessandro Valle; Giampiero Porzio; Benedetta Veruska Costanzo; Flavio Fusco; Federica Aielli; Claudio Adile; Bruna Fara; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2011-05-31       Impact factor: 3.612

6.  Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit.

Authors:  Sebastiano Mercadante; Claudio Adile; Patrizia Ferrera; Andrea Cortegiani; Alessandra Casuccio
Journal:  Curr Med Res Opin       Date:  2017-05-05       Impact factor: 2.580

Review 7.  Palliative care in Italy: problem areas emerging from the literature.

Authors:  S Mercadante; V Vitrano
Journal:  Minerva Anestesiol       Date:  2010-07-08       Impact factor: 3.051

8.  Controlled sedation for refractory symptoms in dying patients.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Villari; Patrizia Ferrera; Fabrizio David; Alessandra Casuccio
Journal:  J Pain Symptom Manage       Date:  2008-11-28       Impact factor: 3.612

9.  Agitation and delirium at the end of life: "We couldn't manage him".

Authors:  William Breitbart; Yesne Alici
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

10.  Comprehensive approaches to managing delirium in patients with advanced cancer.

Authors:  Jung Hun Kang; Seong Hoon Shin; Eduardo Bruera
Journal:  Cancer Treat Rev       Date:  2012-09-06       Impact factor: 12.111

View more
  1 in total

1.  Factors Influencing Pain Expression in Patients with Cancer: An Expert Opinion.

Authors:  Sebastiano Mercadante; Flaminia Coluzzi
Journal:  Pain Ther       Date:  2021-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.